Ramipril-Mepha 1.25 mg

Ramipril-Mepha 1.25 mg is a medicine authorised by Swissmedic under authorisation number 65895. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 October 2015 and the authorisation is valid without a time limit. ATC code C09AA05 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 65895
  • ATC C09AA05
  • Synthetic medicines
Authorisation data
Authorisation number65895
NameRamipril-Mepha 1.25 mg
Full nameRamipril-Mepha 1.25 mg, Tabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09AA05
First authorisation02 October 2015
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Ramipril-Mepha 1.25 mg, TablettenB02 October 2015
2Ramipril-Mepha 2.5 mg, TablettenB02 October 2015
3Ramipril-Mepha 5 mg, TablettenB02 October 2015
4Ramipril-Mepha 10 mg, TablettenB02 October 2015

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
120Tablette(n)C09AA0502.07.1.B
2100Tablette(n)C09AA0502.07.1.B
320Tablette(n)C09AA0502.07.1.B
4100Tablette(n)C09AA0502.07.1.B
520Tablette(n)C09AA0502.07.1.B
6100Tablette(n)C09AA0502.07.1.B
720Tablette(n)C09AA0502.07.1.B
8100Tablette(n)C09AA0502.07.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ramipril-Mepha 1.25 mg authorised in Switzerland?

Yes. Ramipril-Mepha 1.25 mg is authorised by Swissmedic under authorisation number 65895, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Ramipril-Mepha 1.25 mg have?

Ramipril-Mepha 1.25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ramipril-Mepha 1.25 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com